AI-based support for optical coherence tomography in age-related macular degeneration

Abstract Artificial intelligence (AI) has emerged as a transformative technology across various fields, and its applications in the medical domain, particularly in ophthalmology, has gained significant attention. The vast amount of high-resolution image data, such as optical coherence tomography (OC...

Full description

Bibliographic Details
Main Authors: Virginia Mares, Marcio B. Nehemy, Hrvoje Bogunovic, Sophie Frank, Gregor S. Reiter, Ursula Schmidt-Erfurth
Format: Article
Language:English
Published: BMC 2024-04-01
Series:International Journal of Retina and Vitreous
Subjects:
Online Access:https://doi.org/10.1186/s40942-024-00549-1
_version_ 1797209150260772864
author Virginia Mares
Marcio B. Nehemy
Hrvoje Bogunovic
Sophie Frank
Gregor S. Reiter
Ursula Schmidt-Erfurth
author_facet Virginia Mares
Marcio B. Nehemy
Hrvoje Bogunovic
Sophie Frank
Gregor S. Reiter
Ursula Schmidt-Erfurth
author_sort Virginia Mares
collection DOAJ
description Abstract Artificial intelligence (AI) has emerged as a transformative technology across various fields, and its applications in the medical domain, particularly in ophthalmology, has gained significant attention. The vast amount of high-resolution image data, such as optical coherence tomography (OCT) images, has been a driving force behind AI growth in this field. Age-related macular degeneration (AMD) is one of the leading causes for blindness in the world, affecting approximately 196 million people worldwide in 2020. Multimodal imaging has been for a long time the gold standard for diagnosing patients with AMD, however, currently treatment and follow-up in routine disease management are mainly driven by OCT imaging. AI-based algorithms have by their precision, reproducibility and speed, the potential to reliably quantify biomarkers, predict disease progression and assist treatment decisions in clinical routine as well as academic studies. This review paper aims to provide a summary of the current state of AI in AMD, focusing on its applications, challenges, and prospects.
first_indexed 2024-04-24T09:50:07Z
format Article
id doaj.art-a1b8111bb5a94c2a96baf515cf71d88e
institution Directory Open Access Journal
issn 2056-9920
language English
last_indexed 2024-04-24T09:50:07Z
publishDate 2024-04-01
publisher BMC
record_format Article
series International Journal of Retina and Vitreous
spelling doaj.art-a1b8111bb5a94c2a96baf515cf71d88e2024-04-14T11:24:01ZengBMCInternational Journal of Retina and Vitreous2056-99202024-04-0110111110.1186/s40942-024-00549-1AI-based support for optical coherence tomography in age-related macular degenerationVirginia Mares0Marcio B. Nehemy1Hrvoje Bogunovic2Sophie Frank3Gregor S. Reiter4Ursula Schmidt-Erfurth5Laboratory for Ophthalmic Image Analysis, Department of Ophthalmology and Optometry, Medical University of ViennaDepartment of Ophthalmology, Federal University of Minas GeraisLaboratory for Ophthalmic Image Analysis, Department of Ophthalmology and Optometry, Medical University of ViennaLaboratory for Ophthalmic Image Analysis, Department of Ophthalmology and Optometry, Medical University of ViennaLaboratory for Ophthalmic Image Analysis, Department of Ophthalmology and Optometry, Medical University of ViennaLaboratory for Ophthalmic Image Analysis, Department of Ophthalmology and Optometry, Medical University of ViennaAbstract Artificial intelligence (AI) has emerged as a transformative technology across various fields, and its applications in the medical domain, particularly in ophthalmology, has gained significant attention. The vast amount of high-resolution image data, such as optical coherence tomography (OCT) images, has been a driving force behind AI growth in this field. Age-related macular degeneration (AMD) is one of the leading causes for blindness in the world, affecting approximately 196 million people worldwide in 2020. Multimodal imaging has been for a long time the gold standard for diagnosing patients with AMD, however, currently treatment and follow-up in routine disease management are mainly driven by OCT imaging. AI-based algorithms have by their precision, reproducibility and speed, the potential to reliably quantify biomarkers, predict disease progression and assist treatment decisions in clinical routine as well as academic studies. This review paper aims to provide a summary of the current state of AI in AMD, focusing on its applications, challenges, and prospects.https://doi.org/10.1186/s40942-024-00549-1Age-related macular degenerationAnti-VEGFArtificial intelligenceChoroidal neovascularizationDeep learningDrusen
spellingShingle Virginia Mares
Marcio B. Nehemy
Hrvoje Bogunovic
Sophie Frank
Gregor S. Reiter
Ursula Schmidt-Erfurth
AI-based support for optical coherence tomography in age-related macular degeneration
International Journal of Retina and Vitreous
Age-related macular degeneration
Anti-VEGF
Artificial intelligence
Choroidal neovascularization
Deep learning
Drusen
title AI-based support for optical coherence tomography in age-related macular degeneration
title_full AI-based support for optical coherence tomography in age-related macular degeneration
title_fullStr AI-based support for optical coherence tomography in age-related macular degeneration
title_full_unstemmed AI-based support for optical coherence tomography in age-related macular degeneration
title_short AI-based support for optical coherence tomography in age-related macular degeneration
title_sort ai based support for optical coherence tomography in age related macular degeneration
topic Age-related macular degeneration
Anti-VEGF
Artificial intelligence
Choroidal neovascularization
Deep learning
Drusen
url https://doi.org/10.1186/s40942-024-00549-1
work_keys_str_mv AT virginiamares aibasedsupportforopticalcoherencetomographyinagerelatedmaculardegeneration
AT marciobnehemy aibasedsupportforopticalcoherencetomographyinagerelatedmaculardegeneration
AT hrvojebogunovic aibasedsupportforopticalcoherencetomographyinagerelatedmaculardegeneration
AT sophiefrank aibasedsupportforopticalcoherencetomographyinagerelatedmaculardegeneration
AT gregorsreiter aibasedsupportforopticalcoherencetomographyinagerelatedmaculardegeneration
AT ursulaschmidterfurth aibasedsupportforopticalcoherencetomographyinagerelatedmaculardegeneration